🇺🇸 FDA
Pipeline program

Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

060801

Approved mab completed

Quick answer

Octocog alfa (recombinant human coagulation factor VIII) [ADVATE] for Hemophilia A is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hemophilia A
Phase
Approved
Modality
mab
Status
completed

Clinical trials